ANDREW BADACHHAPE to Cell Line, Tumor
This is a "connection" page, showing publications ANDREW BADACHHAPE has written about Cell Line, Tumor.
Connection Strength
0.179
-
Biodegradable nanofibrous drug-eluting seed for sustained intratumoral immunotherapy. J Control Release. 2026 07 10; 395:115004.
Score: 0.034
-
Investigating the oncogenic role of aberrant EZH2 in hepatoblastoma. Sci Rep. 2026 Feb 06; 16(1).
Score: 0.034
-
Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
Score: 0.033
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.027
-
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat Commun. 2022 06 28; 13(1):3728.
Score: 0.026
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
Score: 0.024